(2018). Cryptosporidium spp. CP15 and CSL protein-derived synthetic peptides’ immunogenicity and in vitro seroneutralisation capability.
Chicago Style (17th ed.) CitationCryptosporidium Spp. CP15 and CSL Protein-derived Synthetic Peptides’ Immunogenicity and in Vitro Seroneutralisation Capability. 2018.
MLA (8th ed.) CitationCryptosporidium Spp. CP15 and CSL Protein-derived Synthetic Peptides’ Immunogenicity and in Vitro Seroneutralisation Capability. 2018.
Warning: These citations may not always be 100% accurate.